<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Beta-catenin, a component of the Wingless/Wnt signaling pathway, can activate target genes linking with the <z:mpath ids='MPATH_271'>adenomatous polyposis coli</z:mpath> (APC) gene in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study is to investigate whether nuclear beta-catenin overexpression in metastatic sentinel lymph node(s) [SLN(s)] is associated with synchronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Clinicopathological data from 355 patients (93 cases with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> and 262 cases without <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e>) were reviewed </plain></SENT>
<SENT sid="3" pm="."><plain>Beta-catenin expression in metastatic SLN(s) and liver metastatic lesions was examined by immunohistochemistry </plain></SENT>
<SENT sid="4" pm="."><plain>The association of nuclear beta-catenin expression in metastatic SLN(s) and liver metastatic lesions was evaluated, and the relationship between nuclear beta-catenin expression and clinicopathological characteristics was analyzed </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, univariate and logistic multivariate regression analyses were adopted to discriminate the risk factors of <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Nuclear beta-catenin overexpression in metastatic SLN(s) was observed in 70 patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> and 31 patients without <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> (75.3% vs. 11.8%; P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>Nuclear beta-catenin expression was noted in <z:hpo ids='HP_0000001'>all</z:hpo> the metastatic lesions </plain></SENT>
<SENT sid="8" pm="."><plain>Spearman rank correlation analysis demonstrated that nuclear beta-catenin expression in metastatic SLN(s) had a positive correlation with that in metastatic lesions (r = 0.425, P &lt; 0.001) </plain></SENT>
<SENT sid="9" pm="."><plain>Univariate and multivariate analyses indicated that nuclear beta-catenin overexpression in metastatic SLN(s) correlated with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Nuclear beta-catenin overexpression in metastatic SLN(s) is strongly associated with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> and may contribute to predict <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
</text></document>